Search Results for "EyleaHD"
Phase 2/3 Clinical Trial Data for EYLEA HD® (aflibercept) Injection 8 mg for the Treatment of DME
Sponsored Content
Phase 3 Clinical Trial Data for EYLEA HD® (aflibercept) Injection 8 mg for the Treatment of Wet AMD
Sponsored Content
Editorially Independent content supported by Genentech.
Editorially Independent Content Supported by Genentech and Astellas.
View More